cancer cell made in 3d software

An Update on Immuno-Oncologic Therapeutics to Improve Outcomes for Patients With Advanced Melanoma

Course Information

Therapautic Area: Oncology
Format(s): Webcast, Downloadable Transcript
Credit(s): 1.0 AMA PRA Category 1 Credit(s)™
Activity Dates: March 13, 2017-March 12, 2018


Program Overview

This CME activity will provide an update of clinical trial data as well therapeutic science as it relates to patients with advanced melanoma. Expert faculty will discuss the benefits and drawbacks of immuno-oncology combination therapy regimens in this patient population. The faculty will discuss best practices for engaging all members of the multidisciplinary team in creating individualized treatment plans to improve outcomes and quality of life. Upon completing this activity, physicians will gain a better understanding of optimal treatment options for patients with advanced melanoma.

Target Audience

Dermatologists, oncologists, and other healthcare clinicians responsible for the care of patients with melanoma.

Learning Objectives

  1. Review the therapeutic science of melanoma, including the role of immuno-oncologic agents for the treatment of previously untreated and/or metastatic disease.
  2. Analyze clinical trial data of emerging immuno-oncology combination regimens for the treatment of advanced melanoma.



Jeffrey WeberJeffrey Weber, MD, PhD
Deputy Director, Laura and Isaac Perlmutter Cancer Center
NYU-Langone Medical Center
New York, NY



Darrell-Rigel-1Darrell Rigel, MD, MS
Clinical Professor of Dermatology
New York University School of Medicine
New York, NY


Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty Relationship Identified With:
Jeffrey Weber, MD Consultant/Advisor: Amgen, Inc.; Novartis
Darrell Rigel, MD Nothing to Disclose

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Gilmartin; and Megan Gentile hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Incyte Corporation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Incyte Corporation do not recommend the use of any agent outside of the labeled indications.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact

This activity is expired for CE Credit


Provided by AcademicCME


This CME activity has been supported by an independent educational grant from Incyte Corporation